The current frequency of COVID-19 in a pandemic era ensures that co-infections with a
variety of co-pathogens will occur. Generally, there is a low rate of bonafide co-infections in …

It is possible that parasites may influence the course of COVID-19 infection, as either risk
factors or protective agents; as such, the current coronavirus pandemic may affect the …

Co-infection of COVID-19 with other diseases increases the challenges related to its
treatment management. COVID-19 co-infection with parasites is studied with low frequency …

Here we highlight coinfections of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) with ectoparasites, helminths, and protozoa, described in the literature, and the …

Background The coronavirus Disease 2019 (COVID-19) is a respiratory disease that has
caused extensive ravages worldwide since being declared a pandemic by the World Health …

Background The elimination of lymphatic filariasis (LF) from Brazil by 2020 was not
accomplished; however, this goal can be achieved in the upcoming years with the …

Introduction Emerging infectious diseases such as SARS-CoV-2 can cause pandemics and
create a critical risk for humans. In a previous pilot study, we reported that the immunological …

During the overheating investigations of factors that can decrease COVID-19 severity,
coinfection with some parasitic diseases was identified (Gluchowska et al., 2021). In this …

The use of steroids and other immune modulatory therapies in the treatment of severe
COVID-19 pneumonia predisposes patients to the reemergence of opportunistic infections …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which cause coronavirus
disease 2019 (COVID-19), was recorded as the first time in China, in Wuhan City 2019 (1 …